Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: LiPolymer who wrote (3853)	3/4/2000 4:29:00 PM
From: Maximum_Gain	Read Replies (1) \| Respond to of 4140

Gary, The tone of your response was both refreshing, and inciteful. (hard to come by on SNRS message boards) What do you think about this: Sunrise Technologies International (SNRS) Quarterly Earnings Conference Call C. Russell Trenary III, President/CEO March 1, Duration 45 minutes cheetahmail.com President/CEO C. Russell Trenary III of Sunrise Technologies International discusses Q4 results, the pending approval of a new treatment for hyperopia (farsightedness), and a recent executive-level appointment at the company. Sunrise Technologies, which produces and markets high-tech eye care treatment procedures, announced a year-end net loss of $26,145,000 on Dec. 31, 1999 compared with a net loss of $17,821,000 for the same 1998 period. The company, however, has since raised $11.7 million. On Jan. 13, the Ophthalmic Devices Panel unanimously voted to recommend FDA approval of Sunrise?s Hyperion LTK (laser thermal keratoplasty) System for the treatment of low-to-moderate hyperopia. The company conducted two focus panels with ophthalmologists in Portugal and Hawaii. Trenary discusses the comments given by the doctors, including one who tells of experiences with a rival laser-correction procedure. In other Sunrise Technologies news, former Vitamed Chief Operating Officer John Hendrick was appointed to the COO position at the Fremont, CA-based company. ----------------------------------- The 11.7 million looks like it might be getting eaten up by continuing operations.... I sure hope for SNRS sake that the have enough cash to ramp up production.. Sincerely, Maximum Gain